Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Enhanced anti-melanoma efficacy of interferon alfa-2b via inhibition of Shp2.
Win-Piazza H, Schneeberger VE, Chen L, Pernazza D, Lawrence HR, Sebti SM, Lawrence NJ, Wu J. Win-Piazza H, et al. Among authors: schneeberger ve. Cancer Lett. 2012 Jul 1;320(1):81-5. doi: 10.1016/j.canlet.2012.01.034. Epub 2012 Feb 1. Cancer Lett. 2012. PMID: 22306001 Free PMC article.
SHP2E76K mutant promotes lung tumorigenesis in transgenic mice.
Schneeberger VE, Luetteke N, Ren Y, Berns H, Chen L, Foroutan P, Martinez GV, Haura EB, Chen J, Coppola D, Wu J. Schneeberger VE, et al. Carcinogenesis. 2014 Aug;35(8):1717-25. doi: 10.1093/carcin/bgu025. Epub 2014 Jan 30. Carcinogenesis. 2014. PMID: 24480804 Free PMC article.
Preclinical Modeling of KIF5B-RET Fusion Lung Adenocarcinoma.
Huang Q, Schneeberger VE, Luetteke N, Jin C, Afzal R, Budzevich MM, Makanji RJ, Martinez GV, Shen T, Zhao L, Fung KM, Haura EB, Coppola D, Wu J. Huang Q, et al. Among authors: schneeberger ve. Mol Cancer Ther. 2016 Oct;15(10):2521-2529. doi: 10.1158/1535-7163.MCT-16-0258. Epub 2016 Aug 5. Mol Cancer Ther. 2016. PMID: 27496134 Free PMC article.
PARP Inhibitor Activity Correlates with SLFN11 Expression and Demonstrates Synergy with Temozolomide in Small Cell Lung Cancer.
Lok BH, Gardner EE, Schneeberger VE, Ni A, Desmeules P, Rekhtman N, de Stanchina E, Teicher BA, Riaz N, Powell SN, Poirier JT, Rudin CM. Lok BH, et al. Among authors: schneeberger ve. Clin Cancer Res. 2017 Jan 15;23(2):523-535. doi: 10.1158/1078-0432.CCR-16-1040. Epub 2016 Jul 20. Clin Cancer Res. 2017. PMID: 27440269 Free PMC article.
Target engagement imaging of PARP inhibitors in small-cell lung cancer.
Carney B, Kossatz S, Lok BH, Schneeberger V, Gangangari KK, Pillarsetty NVK, Weber WA, Rudin CM, Poirier JT, Reiner T. Carney B, et al. Nat Commun. 2018 Jan 12;9(1):176. doi: 10.1038/s41467-017-02096-w. Nat Commun. 2018. PMID: 29330466 Free PMC article.
Chemosensitive Relapse in Small Cell Lung Cancer Proceeds through an EZH2-SLFN11 Axis.
Gardner EE, Lok BH, Schneeberger VE, Desmeules P, Miles LA, Arnold PK, Ni A, Khodos I, de Stanchina E, Nguyen T, Sage J, Campbell JE, Ribich S, Rekhtman N, Dowlati A, Massion PP, Rudin CM, Poirier JT. Gardner EE, et al. Among authors: schneeberger ve. Cancer Cell. 2017 Feb 13;31(2):286-299. doi: 10.1016/j.ccell.2017.01.006. Cancer Cell. 2017. PMID: 28196596 Free PMC article.